C+D: ASA bans Voy, Juniper and MedExpress weight-loss pill ads
Trade press coverage of Wednesday's rulings adds company responses: MedExpress said it had already pulled the Instagram story after an internal review, and Voy's CMO said the ads were withdrawn during the investigation and will not run again. Juniper did not comment to C+D.
Source: Chemist+Druggist (4 Nov 2026). Image: Chemist+Druggist.
